Pleiotropic impact of constitutive fosB inactivation on nicotine-induced behavioral alterations and stress-related traits in mice

Human Molecular Genetics

Volumn 16, Issue 7, 2007, Pages 820-836

  Zhu, Hongwen ^a   Lee, MoonSook ^a   Agatsuma, Soh ^a   Hiroi, Noboru ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTININE; NICOTINE; QUININE; TRANSCRIPTION FACTOR FOSB;

ANIMAL EXPERIMENT; ARTICLE; AVERSIVE BEHAVIOR; BEHAVIOR DISORDER; BEHAVIORAL STRESS; CONTROLLED STUDY; GENE DELETION; GENE INACTIVATION; GENETIC SUSCEPTIBILITY; KNOCKOUT MOUSE; LOCOMOTION; MALE; MOUSE; NONHUMAN; PLACE PREFERENCE; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSYCHOMOTOR DISORDER; TOBACCO DEPENDENCE;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; CAUDATE NUCLEUS; CORTICOSTERONE; COTININE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOOD PREFERENCES; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; NICOTINE; NUCLEUS ACCUMBENS; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-FOS; PUTAMEN; QUININE; SACCHARIN;

MUS; RODENTIA;

EID: 34447294845     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddm027     Document Type: Article

References (113)

1. World Health Organization. (2006) Tobacco: Deadly in any Form and Disguise, World Health Organization, Geneva, Switzerland.
2. U.S. Department of Health and Human Services. (2004) The Health Consequences of Smoking: What it Means to You, Center for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta, GA.
3. Perkins, K.A., Grobe, J.E., Weiss, D., Fonte, C. and Caggiula, A. (1996) Nicotine preference in smokers as a function of smoking abstinence. Pharmacol. Biochem. Behav., 55, 257-263.
4. Pickworth, W.B., Fant, R.V., Nelson, R.A., Rohrer, M.S. and Henningfield, J.E. (1999) Pharmacodynamic effects of new de-nicotinized cigarettes. Nicotine Tob. Res., 1, 357-364.
5. Shahan, T.A., Bickel, W.K., Madden, G.J. and Badger, G.J. (1999) Comparing the reinforcing efficacy of nicotine containing and de-nicotinized cigarettes: A behavioral economic analysis. Psychopharmacology (Berl.), 147, 210-216.
6. Butschky, M.F., Bailey, D., Henningfield, J.E. and Pickworth, W.B. (1995) Smoking without nicotine delivery decreases withdrawal in 12-hour abstinent smokers. Pharmacol. Biochem Behav., 50, 91-96.
7. Gross, J., Lee, J. and Stitzer, M.L. (1997) Nicotine-containing versus de-nicotinized cigarettes: Effects on craving and withdrawal. Pharmacol. Biochem. Behav., 57, 159-165.
8. Brauer, L.H., Cramblett, M.J., Paxton, D.A. and Rose, J.E. (2001) Haloperidol reduces smoking of both nicotine-containing and denicotinized cigarettes. Psychopharmacology (Berl.), 159, 31-37.
9. Rose, J.E. and Corrigall, W.A. (1997) Nicotine self-administration in animals and humans: Similarities and differences. Psychopharmacology (Berl.), 130, 28-40.
10. Anthony, J., Warner, L.A. and Kessler, R.C. (1994) Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: Basic findings from the National Comorbidity Survey. Exp. Clin. Psychopharmacol., 2, 244-268.
11. Hiroi, N. and Agatsuma, S. (2005) Genetic susceptibility to substance dependence. Mol. Psychiatry, 10, 336-344.
12. Kreek, M.J., Nielsen, D.A., Butelman, E.R. and LaForge, K.S. (2005) Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat. Neurosci., 8 1450-1457.
13. Lipkus, I.M., Barefoot, J.C., Williams, R.B. and Siegler, I.C. (1994) Personality measures as predictors of smoking initiation and cessation in the UNC Alumni Heart Study. Health Psychol., 13, 149-155.
14. Masse, L.C. and Tremblay, R.E. (1997) Behavior of boys in kindergarten and the onset of substance use during adolescence. Arch. Gen. Psychiatry, 54, 62-68.
15. Breslau, N., Peterson, E.L., Schultz, L.R., Chilcoat, H.D. and Andreski, P. (1998). Major depression and stages of smoking. A longitudinal investigation. Arch. Gen. Psychiatry, 55, 161-166.
16. Sher, K.J., Bartholow, B.D. and Wood, M.D. (2000) Personality and substance use disorders: A prospective study. J. Consult Clin. Psychol., 68, 818-829.
17. Breslau, N., Novak, S.P. and Kessler, R.C. (2004) Psychiatric disorders and stages of smoking. Biol. Psychiatry, 55, 69-76.
18. Audrain-McGovern, J., Rodriguez, D., Patel, V., Faith, M.S., Rodgers, K. and Cuevas, J. (2006) How do psychological factors influence adolescent smoking progression? The evidence for indirect effects through tobacco advertising receptivity. Pediatrics, 117, 1216-1225.
19. Sullivan, P.F. and Kendler, K.S. (1999) The genetic epidemiology of smoking. Nicotine Tob. Res., 1 (Suppl. 2), S51-S57.
20. Agatsuma, S., Lee, M., Zhu, H, Chen, K., Shih, J.C., Seif, I. and Hiroi; N. (2006) Monoamine oxidase A knockout mice exhibit impaired nicotine preference but normal responses to novel stimuli. Hum Mol. Genet., 15, 2721-2731.
21. Arinami, T., Ishiguro, H. and Onaivi, E.S. (2000) Polymorphisms in genes involved in neurotransmission in relation to smoking. Eur. J. Pharmacol., 410, 215-226.
22. Lerman, C. and Berrettini, W. (2003) Elucidating the role of genetic factors in smoking behavior and nicotine dependence. Am. J. Med. Genet. B Neuropsychiatr. Genet., 118, 48-54.
23. Hope, B.T., Nye, H.E., Kelz, M.B., Self, D.W., Iadarola, M.J., Nakabeppu, Y., Duman, R.S. and Nestler, E.J. (1994) Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron, 13, 1235-1244.
24. Chen, J., Nye, H.E., Kelz, M.B., Hiroi, N., Nakabeppu, Y., Hope, B.T. and Nestler, E.J. (1995) Regulation of delta FosB and FosB-like proteins by electroconvulsive seizure and cocaine treatments. Mol. Pharmacol. 48, 880-889.
25. Hiroi, N., Brown, J.R., Haile, C.N., Ye, H., Greenberg, M.E. and Nestler, E.J. (1997) FosB mutant mice: Loss of chronic cocaine induction of Fos-related proteins and heightened sensitivity to cocaine's psychomotor and rewarding effects. Proc. Natl Acad. Sci. USA, 94, 10397-10402.
26. Marttila, K., Raattamaa, H. and Ahtee, L. (2006) Effects of chronic nicotine administration and its withdrawal on striatal FosB/DeltaFosB and c-Fos expression in rats and mice. Neuropharmacology, 51 44-51.
27. Perrotti, L.I., Bolanos, C.A., Choi, K.H., Russo, S.J., Edwards, S., Ulery, P.G., Wallace, D.L., Self, D.W., Nestler, E.J. and Barrot, M. (2005) DeltaFosB accumulates in a GABAergic cell population in the posterior tail of the ventral tegmental area after psychostimulant treatment. Eur. J. Neurosci., 21, 2817-2824.
28. Conversi, D., Bonito-Oliva, A., Orsini, C. and Cabib, S. (2006) Habituation to the test cage influences amphetamine-induced locomotion and Fos expression and increases FosB/DeltaFosB-like inummoreactivity in mice. Neuroscience, 141, 597-605.
29. Andersson, M., Westin, J.E. and Cenci, M.A. (2003) Time course of striatal DeltaFosB-like immunoreactivity and prodynorphin mRNA levels after discontinuation of chronic dopaminomimetic treatment. Eur. J. Neurosci., 17, 661-666.
30. Kelz, M.B., Chen, J., Carlezon, W.A., Jr, Whisler, K., Gilden, L., Beckmann, A.M., Steffen, C., Zhang, Y.J., Marotti, L., Self, D.W. et al. (1999) Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine. Nature, 401, 272-276.
31. Colby, C.R., Whisler, K., Steffen, C., Nestler, E.J. and Self, D.W. (2003) Striatal cell type-specific overexpression of DeltaFosB enhances incentive for cocaine. J. Neurosci., 23, 2488-2493.
32. McClung, C.A. and Nestler, E.J. (2003) Regulation of gene expression and cocaine reward by CREB and DeltaFosB. Nat. Neurosci., 6, 1208-1215.
33. Zachariou, V., Bolanos, C.A., Selley, D.E., Theobald, D., Cassidy, M.P., Kelz, M.B., Shaw-Lutchman, T., Berton, O., Sim-Selley, L.J., Dileone, R.J.. Kumar, A. and Nestler, E.J. (2006) An essential role for DeltaFosB in the nucleus accumbens in morphine action. Nat. Neurosci., 9 205-211.
34. Hiroi, N., Marek, G.J., Brown, J.R., Ye, H., Saudou, F., Vaidya, V.A., Duman, R.S., Greenberg, M.E. and Nestler, E.J. (1998) Essential role of the fosB gene in molecular, cellular, and behavioral actions of chronic electroconvulsive seizures. J. Neurosci., 18, 6952-6962.
35. Perrotti, L.I., Hadeishi, Y., Ulery, P.G., Barrot, M., Monteggia, L., Duman, R.S. and Nestler, E.J. (2004) Induction of deltaFosB in reward-related brain structures after chronic stress. J. Neurosci. 24, 10594-10602.
36. White, N.M. and Hiroi, N. (1993) Amphetamine cue preference and the neurobiology of drug-seeking. Semin. Neurosci., 5, 329-336.
37. Tzschentke, T.M. (1998) Measuring reward with the conditioned place preference paradigm: A comprehensive review of drug effects, recent progress and new issues. Prog. Neurobiol., 56, 613-672.
38. Bardo, M.T. and Bevins, R.A. (2000) Conditioned place preference: What does it add to our preclinical understanding of drug reward? Psychopharmacology (Berl.), 153, 31-43.
39. Pietila, K., Salminen, O., Leikola-Pelho, T. and Ahtee, L. (1996) Tolerance to nicotine's effects on striatal dopamine metabolism in nicotine-withdrawn mice. Eur. J. Pharmacol., 318, 17-22.
40. Pietila, K., Lahde, T., Attila, M., Ahtee, L. and Nordberg, A. (1998) Regulation of nicotinic receptors in the brain of mice withdrawn from chronic oral nicotine treatment. Naunyn Schmiedebergs Arch. Pharmacol., 357, 176-182.
41. Sparks, J.A. and Pauly, J.R. (1999) Effects of continuous oral nicotine administration on brain nicotinic receptors and responsiveness to nicotine in C57B1/6 mice. Psychopharmacology (Berl.), 141, 145-153.
42. Gaddnas, H., Pietila, K. and Ahtee, L. (2000) Effects of chronic oral nicotine treatment and its withdrawal on locomotor activity and brain monoamines in mice. Behav. Brain Res., 113, 65-72.
43. Pietila, K. and Ahtee, L. (2000) Chronic nicotine administration in the drinking water affects the striatal dopamine in mice. Pharmacol. Biochem Behav., 66, 95-103.
44. Gaddnas, H., Pietila, K., Piepponen, T.P. and Ahtee, L. (2001) Enhanced motor activity and brain dopamine turnover in mice during long-term nicotine administration in the drinking water. Pharmacol. Biochem. Behav., 70, 497-503.
45. Lee, M., Chen, K., Shih, J.C. and Hiroi, N. (2004) MAO-B knockout mice exhibit deficient habituation of locomotor activity but normal nicotine intake. Genes Brain Behav., 3, 216-227.
46. Zhu, H., Lee, M., Guan, F., Agatsuma, S., Scott, D., Fabrizio, K., Fienberg, A.A. and Hiroi, N. (2005) DARPP-32 phosphorylation opposes the behavioral effects of nicotine. Biol. Psychiatry, 58, 981-989.
47. Korkosz, A., Kolomanska, P., Kowalska, K., Rogowski, A., Radwanska, K., Kaczmarek, L., Mierzejewski, P., Scinska, A., Kostowski, W. and Bienkowski, P. (2004) Dissociation of ethanol and saccharin preference in fosB knockout mice. Physiol. Behav., 82, 391-395.
48. Welzl, H., Battig, K. and Berz, S. (1990) Acute effects of nicotine injection into the nucleus accumbens on locomotor activity in nicotine-naive and nicotine-tolerant rats. Pharmacol. Biochem. Behav. 37, 743-746.
49. Kita, T., Okamoto, M. and Nakashima, T. (1992) Nicotine-induced sensitization to ambulatory stimulant effect produced by daily administration into the ventral tegmental area and the nucleus accumbens in rats. Life Sci., 50, 583-590.
50. Suto, N., Austin, J.D. and Vezina, P. (2001) Locomotor response to novelty predicts a rat's propensity to self-administer nicotine. Psychopharmacology (Berl.), 158, 175-180.
51. Crawley, J.N. (1985) Exploratory behavior models of anxiety in mice. Neurosci. Biobehav. Rev., 9, 37-44.
52. Prut, L. and Belzung, C. (2003) The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: A review. Eur. J. Pharmacol., 463, 3-33.
53. Meijer, M.K., Lemmens, A.G., Van Zutphen, B.F. and Baumans, V. (2005) Urinary corticosterone levels in mice in response to intraperitoneal injections with saline. J. Appl. Anim. Welf. Sci., 8, 279-283.
54. van Bogaert, M.J., Groenink, L., Oosting, R.S., Westphal, K.G., van der Gugten, J. and Olivier, B. (2006) Mouse strain differences in autonomic responses to stress. Genes Brain Behav., 5, 139-149.
55. Crawley, J.N. (2000) What's Wrong with My Mouse?: Behavioral Phenotyping of Transgenic and Knockout Mice. John Wiley & Sons, New York.
56. Misslin, R., Herzog, F., Koch, B. and Ropartz, P. (1982) Effects of isolation, handling and novelty on the pituitary-adrenal response in the mouse. Psychoneuroendocrinology, 7, 217-221.
57. Carola, V., D'Olimpio, F., Brunamonti, E., Mangia, F. and Renzi, P. (2002) Evaluation of the elevated plus-maze and open-field tests for the assessment of anxiety-related behaviour in inbred mice. Behav. Brain Res., 134, 49-57.
58. Reuter, M., Netter, P., Rogausch, A., Sander, P., Kaltschmidt, M., Dorr, A. and Hennig, J. (2002) The role of cortisol suppression on craving for and satisfaction from nicotine in high and low impulsive subjects. Hum. Psychopharmacol., 17, 213-224.
59. Johnson, D.H., Svensson, A.I., Engel, J.A. and Soderpalm, B. (1995) Induction but not expression of behavioural sensitization to nicotine in the rat is dependent on glucocorticoids. Eur. J. Pharmacol, 276 155-164.
60. Steru, L., Chermat, R., Thierry, B. and Simon, P. (1985) The tail suspension test: A new method for screening antidepressants in mice. Psychopharmacology (Berl.), 85, 367-370.
61. Cryan, J.F., Mombereau, C. and Vassout, A. (2005) The tail suspension test as a model for assessing antidepressant activity: Review of pharmacological and genetic studies in mice. Neurosci. Biobehav. Rev. 29, 571-625.
62. Liu, X. and Gershenfeld, H.K. (2003) An exploratory factor analysis of the Tail Suspension Test in 12 inbred strains of mice and an F2 intercross. Brain Res. Bull., 60, 223-231.
63. Gruda, M.C., van, A.J., Rizzo, C.A., Durham, S.K., Lira, S. and Bravo, R. (1996) Expression of FosB during mouse development: Normal development of FosB knockout mice. Oncogene, 12, 2177-2185.
64. Mandelzys, A., Gruda, M.A., Bravo, R. and Morgan, J.I. (1997) Absence of a persistently elevated 37 kDa fos-related antigen and AP-1-like DNA-binding activity in the brains of kainic acid-treated fosB null mice. J. Neurosci., 17, 5407-5415.
65. Brown, J.R., Ye, H., Bronson, R.T., Dikkes, P. and Greenberg, M.E. (1996) A defect in nurturing in mice lackimg the immediate early gene fosB. Cell, 86, 297-309.
66. Baik, J.H., Picetti, R., Saiardi, A., Thiriet, G., Dierich, A., Depaulis, A., Le, M.M. and Borrelli, E. (1995) Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature 377, 424-428.
67. Kelly, M.A., Rubinstein, M., Phillips, T.J.,.Lessov, C.N., Burkhart-Kasch, S., Zhang, G., Bunzow, J.R., Fang, Y., Gerhardt, G.A., Grandy, D.K. and Low, M.J. (1998) Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations. J. Neurosci., 18, 3470-3479.
68. Ivanco, T.L. and Greenough, W.T. (2002) Altered mossy fiber distributions in adult Fmr1 (FVB) knockout mice. Hippocampus, 12, 47-54.
69. Mineur, Y.S. and Crusio, W.E. (2002) Behavioral and neuroanatomical characterization of FVB/N inbred mice. Brain Res. Bull., 57, 41-47.
70. Silver, L.M. (1995) Mouse Genetics - Concepts and Applications. Oxford University Press, New York.
71. Flaherty, L. and Bolivar, V. (2007) Congenic and consomic strains. In Jones, B.C. and Mormede, P. (eds), Neurobehavioral Genetics.. Taylor & Francis, New York, pp. 115-127.
72. Risinger, F.O. and Oakes, R.A. (1995) Nicotine-induced conditioned place preference and conditioned place aversion in mice. Pharmacol. Biochem. Behav., 51, 457-461.
73. Berrendero, F., Kieffer, B.L. and Maldonado, R. (2002) Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in mu-opioid receptor knock-out mice. J. Neurosci., 22, 10935-10940.
74. Berrendero, F., Mendizabal, V., Robledo, P., Galeote, L., Bilkei-Gorzo, A., Zimmer, A. and Maldonado, R. (2005) Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene. J. Neurosci., 25, 1103-1112.
75. Walters, C.L, Cleck, J.N., Kuo, Y.C. and Blendy, J.A. (2005) Mu-opioid receptor and CREB activation are required for nicotine reward. Neuron 46, 933-943.
76. Grabus, S.D., Martin, B.R., Brown, S.E. and Damaj, M.I. (2006) Nicotine place preference in the mouse: Influences of prior handling, dose and strain and attenuation by nicotinic receptor antagonists. Psychopharmacology (Berl.), 184, 456-463.
77. Walters, C.L., Brown, S., Changeux, J.P., Martin, B. and Damaj, M.I. (2006) The beta2 but not alpha7 subunit of the nicotinic acetylcholine receptor is required for nicotine-conditioned place preference in mice. Psychopharmacology (Berl.), 184, 339-344.
78. Spina, L., Fenu, S., Longoni, R., Rivas, E. and Di, C.G. (2006) Nicotine-conditioned single-trial place preference: Selective role of nucleus accumbens shell dopamine D1 receptors in acquisition. Psychopharmacology (Berl.), 184, 447-455.
79. Corrigall, W.A., Franklin, K.B., Coen, K.M. and Clarke, P.B. (1992) The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology (Berl.), 107, 285-289.
80. Laviolette, S.R. and van der Kooy, D. (2003) The motivational valence of nicotine in the rat ventral tegmental area is switched from rewarding to aversive following blockade of the alpha7-subunit-containing nicotinic acetylcholine receptor, Psychopharmacology (Berl.), 166, 306-313.
81. Ikemoto, S., Qin, M. and Liu, Z.H. (2006) Primary reinforcing effects of nicotine are triggered from multiple regions both inside and outside the ventral tegmental area. J. Neurosci., 26, 723-730.
82. Maskos, U., Molles, B.E., Pons, S., Besson, M., Guiard, B.P., Guilloux, J.P., Evrard, A., Cazala, P., Cormier, A., Mameli-Engvall, M. et al. (2005) Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature, 436, 103-107.
83. Pich, E.M., Pagliusi, S.R., Tessari, M., Talabot-Ayer, D., Hooft van, H.R. and Chiamulera, C. (1997) Common neural substrates for the addictive properties of nicotine and cocaine. Science, 275, 83-86.
84. Mumberg, D., Lucibello, F.C., Schuermann, M. and Muller, R. (1991) Alternative splicing of fosB transcripts results in differentially expressed mRNAs encoding functionally antagonistic proteins. Genes Dev., 5, 1212-1223.
85. Nakabeppu, Y. and Nathans, D. (1991) A naturally occurring truncated form of FosB that inhibits Fos/Jun transcriptional activity. Cell, 64, 751-759.
86. Yen, J., Wisdom, R.M., Tratner, I. and Verma, I.M. (1991) An alternative spliced form of FosB is a negative regulator of transcriptional activation and transformation by Fos proteins. Proc Natl Acad. Sci. USA, 88, 5077-5081.
87. Wisdom, R., Yen, J., Rashid, D. and Verma, I.M. (1992) Transformation by FosB requires a trans-activation domain missing in FosB2 that can be substituted by heterologous activation domains. Genes Dev., 6 667-675.
88. Chen, J., Zhang, Y., Kelz, M.B., Steffen, C., Ang, E.S., Zeng, L. and Nestler, E.J. (2000) Induction of cyclin-dependent kinase 5 in the hippocampus by chronic electroconvulsive seizures: Role of [Delta]FosB. J. Neurosci., 20, 8965-8971.
89. Carlezon, W.A., Jr, Thome, J., Olson, V.G., Lane-Ladd, S.B., Brodkin, E.S., Hiroi, N., Duman, R.S., Neve, R.L. and Nestler, E.J. (1998) Regulation of cocaine reward by CREB. Science, 282, 2272-2275.
90. Walters, C.L. and Blendy, J.A. (2001) Different requirements for cAMP response element binding protein in positive and negative reinforcing properties of drugs of abuse. J. Neurosci., 21, 9439-9444.
91. Haile, C.N., Hiroi, N., Nestler, E.J. and Kosten, T.A. (2001) Differential behavioral responses to cocaine are associated with dynamics of mesolimbic dopamine proteins in Lewis and Fischer 344 rats. Synapse, 41, 179-190.
92. Horan, B., Smith, M., Gardner, E.L., Lepore, M. and Ashby, C.R., Jr. (1997) (-)-Nicotine produces conditioned place preference in Lewis, but not Fischer 344 rats. Synapse, 26, 93-94.
93. Shiffman. S. (1989) Tobacco 'chippers'-individual differences in tobacco dependence. Psychopharmacology (Berl.), 97, 539-547.
94. Picciotto, M.R. (2003) Nicotine as a modulator of behavior: Beyond the inverted U. Trends Pharmacol Sci., 24, 493-499.
95. O'Brien, C.P. and Gardner, E.L. (2005) Critical assessment of how to study addiction and its treatment: Human and non-human animal models. Pharmacol. Ther., 108, 18-58.
96. Niaura, R.S., Rohsenow, D.J., Binkoff, J.A., Monti, P.M., Pedraza, M. and Abrams, D.B. (1999) Relevance of cue reactivity to understanding alcohol and smoking relapse. J. Abnorm. Psychol., 97, 133-152.
97. Droungas, A., Ehrman, R.N., Childress, A.R. and O'Brien, C.P. (1995) Effect of smoking cues and cigarette availability on craving and smoking behavior. Addict. Behav., 20, 657-673.
98. Shiffman, S., Paty, J.A., Gays, M., Kassel, J.A. and Hickcox, M. (1996) First lapses to smoking: Within-subjects analysis of real-time reports. J. Consult. Clin. Psychol., 64, 366-379.
99. Goldberg, S.R., Spealman, R.D. and Goldberg, D.M. (1981) Persistent behavior at high rates maintained by intravenous self-administration of nicotine. Science, 214, 573-575.
100. Cohen, C., Perrault, G., Griebel, G. and Soubrie, P. (2005) Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: Reversal by the cannabinoid (CB1) receptor antagonist, rimonabant (SR141716). Neuropsychopharmacology, 30, 145-155.
101. Chaudhri, N., Caggiula, A.R., Donny, E.C., Palmatier, M.I., Liu, X. and Sved, A.F. (2006) Complex interactions between nicotine and nonpharmacological stimuli reveal multiple roles for nicotine in reinforcement. Psychopharmacology (Berl.), 184, 353-366.
102. Karasinska, J.M., George, S.R., Cheng, R. and O'Dowd, B.F. (2005) Deletion of doparmine D1 and D3 receptors differentially affects spontaneous behaviour and cocaine-induced locomotor activity, reward and CREB phosphorylation. Eur. J. Neurosci., 22, 1741-1750.
103. Dulawa, S.C., Grandy, D.K., Low, M.J., Paulus, M.P. and Geyer, M.A. (1999) Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli. J. Neurosci., 19, 9550-9556.
104. Belzung, C. and Le Pape, G. (1994) Comparison of different behavioral test situations used in psychopharmacology for measurement of anxiety. Physiol. Behav., 56, 623-628.
105. Kliethermes, C.L. and Crabbe, J.C. (2006) Genetic independence of mouse measures of some aspects of novelty seeking. Proc. Natl Acad. Sci. USA, 103, 5018-5023.
106. Miyata, S., Hirano, S. and Kamei, J. (2004) Diabetes attenuates the antidepressant-like effect mediated by the activation of 5-HT1A receptor in the mouse tail suspension test. Neuropsychopharmacology, 29 461-469.
107. Timpl, P., Spanagel, R., Sillaber, I., Kresse, A., Reul, J.M., Stalla, G.K., Blanquet, V., Steckler, T., Holsboer, F. and Wurst, W. (1998,) Impaired stress response and reduced anxiety in mice lacking a functional corticottopin-releasing hormone receptor 1. Nat. Genet. 19, 162-166.
108. Misslin, R. and Cigrang, M. (1986) Does neophobia necessarily imply fear or anxiety? Behav. Process., 12, 45-50.
109. Goeders, N.E. (2002) Stress and cocaine addiction. J. Pharmacol. Exp. Ther., 301, 785-789.
110. Marinelli, M. and Piazza, P.V. (2002) Interaction between glucocorticoid hormones, stress and psychostimulant drugs. Eur. J. Neurosci., 16, 387-394.
111. Crowley, J.J., Jones, M.D., O'Leary, O.F. and Lucki, I. (2004) Automated tests for measuring the effects of antidepressants in mice. Pharmacol. Biochem. Behav., 78, 269-274.
112. Hiroi, N. and Graybiel, A.M. (1996) Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum. J. Comp. Neurol., 374, 70-83.
113. Grande, C., Zhu, H., Martin, A.B., Lee, M., Ortiz, O., Hiroi, N. and Moratalla, R. (2004) Chronic treatment with atypical neuroleptics induces striosomal FosB/DeltaFosB expression in rats. Biol. Psychiatry, 55, 457-463.